HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Willem Flameng Bart Meuris Paul Herijgers Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flameng, W. Articles by Herregods, M.-C. Search for Related Content PubMed Articles by Flameng, W. Articles by Herregods, M.-C. Related Collections Valve disease

J Thorac Cardiovasc Surg 2008;135:274-282
© 2008 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

Durability of mitral valve repair in Barlow disease versus fibroelastic deficiency

^a Cardiac Surgery, Department of Cardiovascular Diseases, Katholieke Universiteit Leuven, Leuven, Belgium
^b Cardiology, Department of Cardiovascular Diseases, Katholieke Universiteit Leuven, Leuven, Belgium

Received for publication February 2, 2007; revisions received June 12, 2007; accepted for publication June 14, 2007.

^_* Address for reprints: Willem Flameng, MD, PhD, Cardiac Surgery, University Clinic Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. (Email: willem.flameng{at}med.kuleuven.ac.be).

Objective: Durability assessment of mitral valve repair for degenerative valve incompetence is limited to reoperation as a primary indicator and valve-related risk factors for late death as a secondary indicator. We assessed serial echocardiographic follow-up of valve function as an indicator of the durability of mitral valve repair.

Methods and Results: In 348 patients having undergone mitral valve repair for degenerative valve incompetence, clinical outcome was excellent: 10 years after repair, survival was 80.1% and freedom from reoperation 94.4%. However, freedom from mitral regurgitation (>2/4), 98.7% at 1 month, decreased to 82.2% at 5 years and 64.9% at 10 years. The linearized recurrence rate of mitral regurgitation (>2/4) was 3.2% per year. Recurrence rate was higher in patients with Barlow disease (6.0%) and lower in those with fibroelastic deficiency (2.6%) (P = .01). Performing chordal shortening, the nonuse of sliding plasty and the nonuse of an annuloplasty ring were determined to be factors predicting recurrence of mitral regurgitation. In reconstructions avoiding these risk factors, recurrence rate decreased to 2.4%. There was no difference between Barlow disease and fibroelastic deficiency: 2.9% versus 2.2% (P > .05). Recurrent regurgitation is characterized by leaflet prolapse, thickening, and calcification.

Conclusion: When optimal surgical techniques are used, the residual recurrence rate of mitral valve regurgitation remains between 2% and 3% per year and is related to progressive degeneration of the chordae and the leaflets. Long-term results of mitral valve repair in Barlow disease are essentially the same as in fibroelastic deficiency.

This article has been cited by other articles:

				F. Chenot, P. Montant, D. Vancraeynest, A. Pasquet, B. Gerber, P. H. Noirhomme, G. E. Khoury, and J.-L. Vanoverschelde Long-term clinical outcome of mitral valve repair in asymptomatic severe mitral regurgitation Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 539 - 545. [Abstract] [Full Text] [PDF]

				T. Feldman, S. Kar, M. Rinaldi, P. Fail, J. Hermiller, R. Smalling, P. L. Whitlow, W. Gray, R. Low, H. C. Herrmann, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) Cohort. J. Am. Coll. Cardiol., August 18, 2009; 54(8): 686 - 694. [Abstract] [Full Text] [PDF]

				M. Padala, S. N. Powell, L. R. Croft, V. H. Thourani, A. P. Yoganathan, and D. H. Adams Mitral valve hemodynamics after repair of acute posterior leaflet prolapse: quadrangular resection versus triangular resection versus neochordoplasty. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 309 - 315. [Abstract] [Full Text] [PDF]

				A. M. Gillinov, K. Tantiwongkosri, E. H. Blackstone, P. L. Houghtaling, E. R. Nowicki, J. F. Sabik III, D. R. Johnston, L. G. Svensson, and T. Mihaljevic Is prosthetic anuloplasty necessary for durable mitral valve repair? Ann. Thorac. Surg., July 1, 2009; 88(1): 76 - 82. [Abstract] [Full Text] [PDF]

				D. H. Adams, A. C. Anyanwu, J. Chikwe, and F. Filsoufi The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2389 - 2403. [Full Text] [PDF]

				S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908. [Full Text] [PDF]

				A. E. Newcomb, T. E. David, V. S. Lad, J. Bobiarski, S. Armstrong, and M. Maganti Mitral valve repair for advanced myxomatous degeneration with posterior displacement of the mitral annulus. J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1503 - 1509. [Abstract] [Full Text] [PDF]

				I. Szentkiralyi, A. Peterffy, and Z. Galajda Importance of stabilization of the mitral annulus in mitral valve repair. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1102 - 1103. [Full Text] [PDF]

				D. H. Adams and A. C. Anyanwu Seeking a Higher Standard for Degenerative Mitral Valve Repair: Begin with Etiology J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 551 - 556. [Full Text] [PDF]

				L. P. Ryan, B. M. Jackson, T. J. Eperjesi, T. J. Plappert, M. St John-Sutton, R. C. Gorman, and J. H. Gorman III A methodology for assessing human mitral leaflet curvature using real-time 3-dimensional echocardiography J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 726 - 734. [Abstract] [Full Text] [PDF]